Health Care/Hospital

Yisheng Biopharma and Tavotek Biotherapeutics Announce Strategic Research Alliance for Development of YS-ON-001/002 and Tavo-301/303 Combination Therapy for Cancer Treatment

GAITHERSBURG, Md. and AMBLER, Pa., Jan. 6, 2020 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immunological biologics and vaccines, and Tavotek Biotherapeutics, a biotech c...

2020-01-06 09:00 3167

Colgate Announces Breakthrough Technology Designed To Revolutionize Oral Health

Colgate® Plaqless Pro Smart Electric Toothbrush Wins Innovation Award at CES in Advance of 2020 Launch LAS VEGAS, Jan. 6, 2020 /PRNewswire/ -- Colgate today introduces a first-of-its-kind smart toothbrush with new optic sensor technology that detects biofilm buildup in the mouth so that it can ...

2020-01-06 09:00 2920

Fountain Medical Appoints Mr. Ling Zhen as the Co-Chairman and Chief Executive Officer

BEIJING and SHANGHAI, Jan. 2, 2020 /PRNewswire/ -- Fountain Medical Development Limited ("Fountain Medical" or "Company"), a clinical stage CRO dedicated to offering high-quality one-stop services to pharmaceutical and medical device clients, announced today that Mr.Ling Zhen, J.D., M.B.A., is ap...

2020-01-02 09:30 6791

WuXi Biologics Congratulates OncoImmune on FDA Clearance of IND Application for Next Generation anti-CTLA-4 Antibody ONC-392

SHANGHAI, Jan. 2, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, congratulates its partner OncoImmune on the U.S. Food and Drug ...

2020-01-02 08:08 2806

CF PharmTech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Drugs

SHUZHOU, China, Jan. 2, 2020 /PRNewswire/ -- CF PharmTech, Inc., a pharmaceutical company with a vision to provide quality and affordable respiratory drug products globally, announced it has raised a $90 million Series E investment led by New Alliance Capital. The investment included participati...

2020-01-02 08:00 4943

Oncologie Selected as Top 100 Innovative Pharmaceutical Company in China

SHANGHAI, Dec. 27, 2019 /PRNewswire/ -- Oncologie, a biopharmaceutical company with innovative oncology therapeutics supported by a biomarker platform to select patients, today announced that it has been selected as a Top 100 innovative pharmaceutical company inChina by VCBeat, a renowned healthc...

2019-12-27 21:00 3167

New Major Order From China

STOCKHOLM, Dec. 27, 2019 /PRNewswire/ -- Bactiguard has received a new order from Well Lead Medical (Well Lead) inChina. The order will be delivered promptly and generate revenues in the fourth quarter of approximatelySEK 16.5 million. "This is the second order from Well Lead outside the initial...

2019-12-27 19:37 1958

Focusing on Cutting-edge Biopharmaceutical Technologies, Boosting the Industry to Achieve Innovation and Development

SHANGHAI, Dec. 25, 2019 /PRNewswire/ -- To seize the ever-changing opportunities in the new era and to meet the ever-growing market demands, the annual gala of the biopharmaceutical industry---bioLIVE China 2020, will be held again at Hall W4 in the SNIEC onJune 22-24, 2020. The exhibition, co-l...

2019-12-25 12:55 2926

EpiVax Announces Record Year for Growth in 2019 and Sets New Milestones for 2020

PROVIDENCE, Rhode Island, Dec. 24, 2019 /PRNewswire/ -- EpiVax ("EpiVax, Inc.") continues its record-breaking performance and growth in personnel in 2019 while identifying new milestones to aspire to in 2020. The Business Development team closed 15% more contracts over 2018 and acquired two ne...

2019-12-24 16:35 2097

TOWA PHARMACEUTICAL CO., LTD. reaches an agreement with ESTEVE to acquire ESTEVE's generic division, Pensa Investments

The operation will accelerate TOWA's overseas business presence and provide high-quality and value-added generic medicines to patients. OSAKA, Japan and BARCELONA, Spain, Dec. 23, 2019 /PRNewswire/ -- TOWA PHARMACEUTICAL CO.,LTD. (Osaka, Japan) (TOWA) and ESTEVE (Barcelona, Spain) announced toda...

2019-12-23 17:17 1189

WuXi Biologics Receives "Special Award to Investors in Ireland" from Asia Matters

DUBLIN, Dec. 23, 2019 /PRNewswire/ -- December 23, 2019 – WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it has received the "Special Awa...

2019-12-23 16:26 2313

Holmusk and NHCS Extend Collaboration to Improve Heart Disease Care

SINGAPORE, Dec. 23, 2019 /PRNewswire/ -- Holmusk and National Heart Centre Singapore announced that they have extended their collaboration agreement to improve care for patients with coronary artery disease using machine learning and data analytics, untilDecember 2020. This will build upon the wo...

2019-12-23 13:43 1936

iView Announces First Patient Treated in Phase 2 Clinical Trial Program Evaluating IVIEW-1201 in Patients with Acute Adenoviral Conjunctivitis

HYDERABAD, India, Dec. 23, 2019 /PRNewswire/ -- iView Therapeutics Inc. today announced that the first patient has been dosed in the Phase 2 IVIEW-1201-01-AIC clinical trial program assessing the efficacy of IVIEW-1201 in patients (age ≥15 years) with Acute Adenoviral Conjunctivitis. First subjec...

2019-12-23 08:42 1873

NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study

LUND, Sweden, Dec. 23, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced the completed recruitment of healthy volunteers in the second part of the company's ongoing Phase Ia/b clinical study with candidate drug KL1333, in development for chroni...

2019-12-23 08:33 1352

China's Largest Plasmid and Virus Facility from GenScript in Operation

ZHENJIANG, China, Dec. 20, 2019 /PRNewswire/ -- The CDMO segment of the world's leading biotech company GenScript announced that GenScript's plasmid and virus facility was put into operation onDecember 18, 2019. It is a milestone on the path to industrialization of the gene and cell therapy indus...

2019-12-20 21:59 2903

InxMed Receives Approval to Initiate Phase I Clinical Trial in China for IN10018

BEIJING, Dec. 20, 2019 /PRNewswire/ -- InxMed (Shanghai) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, announced today that the Company has obtained IND (Investigational New Drug) clearan...

2019-12-20 18:21 2402

Hematogenix Announces the Opening of Their Newest Facility in Shanghai, China

TINLEY PARK, Illinois, Dec. 19, 2019 /PRNewswire/ -- Hematogenix® announces the opening of their newest facility inShanghai, China furthering their commitment to be a global leader in the field of cancer research and diagnostic testing. China's growing population is attractive to the pharmaceutica...

2019-12-19 22:07 2102

4G Clinical Launches Innovative Clinical Supply Software Leveraging Natural Language Processing (NLP)

4C Supply™ Empowers Supply Professionals to Build and Analyze Multiple Supply Models Themselves, Providing Speed, Simplicity and Control over Supply Decisions WELLESLEY, Mass., Dec. 19, 2019 /PRNewswire/ -- 4G Clinical today announced the launch of 4C Supply™, a cutting-edge clinical supply optim...

2019-12-19 21:20 1498

Merck Licenses Foundational CRISPR Integration Technology to Promega

- Gives scientists a new view into natural cell activity, accelerating drug development DARMSTADT, Germany, Dec. 19, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that it has signed a license agreement providingPromega Corp., a global life science manufact...

2019-12-19 21:00 2418

Tessa Therapeutics to Open 90,000 Square Foot Commercial-Scale Cell Therapy Manufacturing Facility in Singapore in 2020

* State-of-the-art manufacturing facility will support clinical and commercial production of cell therapies for thousands of patients annually worldwide * Global commercial-scale facility is designed to comply with cGMP guidelines in the U.S.,Europe and Asia * Facility will integrate digita...

2019-12-19 20:00 1266